# Why Biosimilars?
Keywords: biosimilars, biologics, healthcare innovation, patient access, cost savings, rheumatoid arthritis, treatment options

> This page highlights the importance of biosimilars in advancing healthcare innovation, improving patient access to treatments, and reducing costs for healthcare systems. It also discusses their impact on patients and healthcare systems, with specific case studies and data.

## Details
- [Impact on patients](#): Biosimilars expand treatment options and affordability, enabling access for more patients, including those with moderate rheumatoid arthritis.
- [Impact on healthcare systems](#): Biosimilars reduce development time and costs, providing more affordable alternatives to biologics and fostering competition.
- [Improving access with biosimilars](#): Biosimilars drive innovation, enhance treatment availability, and create cost-saving opportunities for healthcare systems.